D

S

DOOSE , Sören

Last name: DOOSE

First name: Sören

December 15, 2022 (v1)

Publication

Metadata-only

Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y)

García-Guerrero, Estefanía Götz, Ralph Doose, Sören

No description

Uploaded on: March 24, 2023
September 28, 2022 (v1)

Publication

Metadata-only

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

García-Guerrero, Estefanía Götz, Ralph Doose, Sören

Multiple myeloma (MM) is incurable, so there is a significant unmet need for effective therapy for patients with relapsed or refractory disease. This situation has not changed despite the recent approval of the anti-CD38 antibody daratumumab, one of the most potent agents in MM treatment. The efficiency of daratumumab might be improved by...

Uploaded on: March 24, 2023